HLS Therapeutics Inc. (TSX:HLS)
Canada flag Canada · Delayed Price · Currency is CAD
4.400
0.00 (0.00%)
At close: Mar 20, 2026

HLS Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
138151125126318487
Market Cap Growth
6.08%20.64%-1.09%-60.28%-34.66%-15.02%
Enterprise Value
189.84190.51174.75195.48397.38565.94
Last Close Price
4.404.823.933.959.8315.00
PE Ratio
--9.00-4.42-3.51-9.92-28.95
PS Ratio
1.812.722.212.005.178.11
PB Ratio
1.632.441.751.292.543.03
P/TBV Ratio
2.252.461.751.302.543.00
P/FCF Ratio
5.938.9115.648.0218.8229.71
P/OCF Ratio
5.868.8015.618.0018.7729.63
EV/Sales Ratio
2.493.433.093.106.469.43
EV/EBITDA Ratio
7.8211.6610.0312.7225.2823.77
EV/EBIT Ratio
--34.74-33.04-11.80-21.27-87.70
EV/FCF Ratio
8.1811.2621.8812.4123.5234.55
Debt / Equity Ratio
0.840.840.940.930.800.62
Debt / EBITDA Ratio
3.153.153.865.936.364.21
Debt / FCF Ratio
3.043.048.425.795.926.13
Net Debt / Equity Ratio
0.650.650.700.710.630.49
Net Debt / EBITDA Ratio
2.442.442.864.505.053.33
Net Debt / FCF Ratio
2.352.356.244.394.704.83
Asset Turnover
0.370.370.310.280.240.21
Inventory Turnover
1.171.170.970.830.560.41
Quick Ratio
0.750.751.101.221.021.18
Current Ratio
1.111.111.571.651.421.58
Return on Equity (ROE)
-18.66%-18.69%-23.26%-24.69%-16.50%-7.95%
Return on Assets (ROA)
-3.55%-3.56%-3.62%-7.28%-7.18%-2.47%
Return on Invested Capital (ROIC)
-4.24%-4.25%-4.35%-8.61%-8.22%-2.79%
Return on Capital Employed (ROCE)
-4.41%-4.41%-3.31%-8.43%-8.15%-2.50%
Earnings Yield
-12.39%-11.11%-22.63%-28.52%-10.08%-3.45%
FCF Yield
16.86%11.23%6.39%12.47%5.31%3.37%
Dividend Yield
-0.00%0.00%2.49%2.11%1.34%
Payout Ratio
-0.00%0.00%-8.71%-21.03%-39.05%
Buyback Yield / Dilution
-1.64%-1.19%-0.48%-1.33%-0.37%-1.02%
Total Shareholder Return
--1.19%-0.48%1.16%1.74%0.32%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.